レスベラトロールは,ポドサイト内のJAML/Sirt1経路経由による脂質収縮を阻害する
Wei Gu1, Xiaolong Li1, Kunjie Zheng1
1Department of Endocrinology, Harrison International Peace Hospital, Hengshui, Hebei 053000, People's Republic of China.
Prostaglandins & other lipid mediators
|February 15, 2026
まとめ
レスベラトロールは,ポドサイトにおける結合粘着分子型タンパク質 (JAML) /サートゥイン1 (Sirt1) 経路を調節することにより,腎臓の脂質堆積を減少させます. この研究では,レスベラトロールの説明が明確になりました.
科学分野:
- ネフロロジーは腎臓科
- 分子生物学は分子生物学である.
- メタボリック疾患
背景:
- 脂質の蓄積は,糖尿病性腎臓病の進行の重要な要因である.
- レスベラトロールは,JAML/Sirt1経路経由で腎臓の脂質合成を調節する可能性を示しています.
- パルミチン酸によって誘発されたポドサイトにおける脂質蓄積に対するレスベラトロールの効果のメカニズムについては,さらなる解明が必要である.
研究 の 目的:
- ネズミのポドサイトにおける新たな脂質合成におけるJAML/Sirt1経路の役割を調査する.
- レスベラトロールがパルミチン酸による脂質の蓄積と代謝に影響を与える特定のメカニズムを解明する.
- レスベラトロールがポドサイト内のJAML/Sirt1経路を調節することにより,細胞内脂質の堆積を抑制するかどうかを決定する.
主な方法:
- マウスポドサイト細胞系5 (MPC-5) を利用して,脂質代謝を研究した.
- de novo脂質合成におけるJAML/Sirt1経路の役割を調査した.
- 経路調節を評価するために,siRNA媒介による静止とJAMLの過剰発現を使用しました.
- SREBP-1,ChREBP,ADRPを含む主要な脂質合成調節体の発現を分析した.
主要な成果:
- レスベラトロールは,PA治療を受けたMPC-5ポドサイトにおけるJAML/Sirt1経路のコンポーネントの異常表現を弱めた.
- JAMLを静止すると,Sirt1の発現が増加し,主要な脂質合成タンパク質 (SREBP-1,ChREBP,ADRP) が低下する.
- JAML過剰発現はこれらの効果を逆転させ,レスベラトロールはJAML過剰発現に関連する代謝異常を軽減しました.
結論:
- レスベラトロールは,JAML/Sirt1経路を調節することにより,ポドサイト内の細胞内脂質の蓄積を抑制します.
- 発見は,腎臓の脂質堆積を改善するレスベラトロールの有効性の証拠を提供します.
- この研究は,脂質の蓄積に関連した腎疾患に対する潜在的な治療戦略を示唆しています.
関連する概念動画
Antihypertensive Drugs: Direct Renin Inhibitors
1.6K
The renin-angiotensin-aldosterone system (RAAS) is an intricate physiological pathway involving numerous enzymes and hormones, including renin, angiotensin-converting enzyme (ACE), angiotensin I and II, and aldosterone. Imbalances within this system increase the production of angiotensin II and aldosterone. Increased angiotensin II levels promote vasoconstriction and blood pressure elevation. Concurrently, higher aldosterone levels stimulate sodium and water reabsorption in the kidneys,...
1.6K
The JAK-STAT Signaling Pathway
13.1K
Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as SH2...
13.1K
Lipid-Lowering Drugs: Statins and Miscellaneous Agents
1.5K
Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
1.5K
Cholesterol: Significance and Regulation
1.5K
Although not a source of energy, cholesterol plays a significant role as a foundational structure for bile salts, steroid hormones, and vitamin D, as well as being a crucial component of plasma membranes. Approximately 15% of blood cholesterol is derived from our diet, with the remainder synthesized from acetyl CoA by the liver and intestines. Cholesterol is eliminated from the body through its conversion into bile salts, which are eventually discarded in the feces.
Considering cholesterol and...
Considering cholesterol and...
1.5K
Lipid Absorption
2.8K
Dietary triglycerides from chyme in the duodenum are mixed with bile salts produced by the liver to emulsify fats. As a result, large droplets are broken down into smaller ones, increasing the surface area for enzymatic action. Once emulsified, pancreatic lipases hydrolyze the triglycerides into free fatty acids and monoglycerides.
These breakdown products bind with bile salts and lecithin to form micelles, which quickly pass between microvilli to come in close contact with the apical...
These breakdown products bind with bile salts and lecithin to form micelles, which quickly pass between microvilli to come in close contact with the apical...
2.8K
PI3K/mTOR/AKT Signaling Pathway
5.7K
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a...
5.7K

